New York, NY – May 1, 2020 – Maxim Group LLC, a leading full service investment banking, securities and wealth management firm today announced the enhancement of its Investment Banking platform with the promotion of Jim Alfaro to Senior Managing Director and Head of Healthcare Investment Banking.
The topic of infectious disease (ID) – particularly amid the COVID-19 pandemic – is dominating the headlines and our daily lives, making the need for new anti-infectives even greater. Indeed, significant resources are being deployed to develop methods to contain, treat and perhaps even cure COVID-19, and to prepare for the next potential pandemic.
COVID-19 is a crisis that is adversely affecting all of us, but clearly presents investment opportunities. As a leading investment bank in the healthcare sector, Maxim Group is well-positioned to connect industry experts with the investment community. We offer our virtual conference to provide a forum for investors to better understand the challenges and opportunities in the ID space.
Please join us to hear from executives representing 16 biotech/pharma companies in various stages of development, from early-stage to commercialization. The virtual conference will not just cover COVID-19, but all three categories of anti-infectives: bacterial, fungal and viral.
Date: Tuesday, May 5, 2020
Time: 10:00am – 5pm ET
COVID-19 Vaccines and Monitoring
If you are interested, please RSVP at https://m-vest.com/insights/blog/Infectious-Disease-Virtual-Conference-2020.